Skip to content

    Spero Therapeutics (SPRO) stock price & financials

    View SPRO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance39.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $13.47M
    $15.04M
    $5.87M
    $14.19M
    $5.44M
    -59.6%
    $41.30M
    +174.5%
    $258.0K
    -95.6%
    $0
    -100.0%
    Weakening
    Operating Profit
    -$18.59M
    -$21.73M
    -$14.73M
    -$2.44M
    -$7.92M
    +57.4%
    $31.41M
    -$7.54M
    +48.8%
    -$9.93M
    -306.1%
    Weakening
    Net Profit
    -$17.15M
    -$20.89M
    -$13.87M
    -$1.70M
    -$7.38M
    +56.9%
    $31.52M
    -$7.20M
    +48.1%
    -$9.55M
    -461.9%
    Weakening
    EPS
    $-0.32
    $-0.25
    $-0.03
    $-0.13
    +59.4%
    $-0.13
    +48.0%
    $-0.16
    -433.3%
    Weakening
    Other Income
    $1.16M
    $1.13M
    $865.0K
    $744.0K
    $534.0K
    -53.8%
    $376.0K
    -66.6%
    $335.0K
    -61.3%
    $374.0K
    -49.7%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -138.0%
    -144.4%
    -250.8%
    -17.2%
    -145.5%
    -5.4%
    76.0%
    -2921.7%
    -1065.0%
    Weakening
    Tax
    ReturnsROIC
    3.7%
    4.5%
    3.0%
    0.4%
    1.6%
    -56.9%
    -6.7%
    -250.9%
    1.5%
    -48.1%
    2.0%
    +461.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$34.08M$29.73M$85.21M$112.58M$109.11M$76.33M$52.89M$40.27M$50.77M
    Short-Term Investments$81.36M$52.31M$41.70M$33.82M$0
    Total Current Assets$124.22M$95.41M$139.15M$157.87M$113.57M$131.21M$107.28M$67.29M$51.58M
    Net PP&E$2.89M$7.15M$8.78M$7.56M$5.49M$4.16M$3.11M$1.48M$1.03M
    Goodwill
    Intangibles
    Total Assets$129.01M$106.10M$153.45M$171.07M$124.80M$182.39M$110.54M$68.92M$52.77M
    LiabilitiesTotal Current Liabilities$12.32M$26.66M$14.34M$18.67M$21.65M$37.15M$49.07M$8.87M$8.43M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$4.62M$6.89M$5.97M$4.96M$3.83M$2.55M$939.0K$43.0K
    Total Liabilities$13.15M$31.53M$21.41M$82.78M$48.87M$75.50M$64.42M$9.90M$8.56M
    EquityCommon Stock & APIC$17.0K$19.0K$29.0K$32.0K$52.0K$53.0K$55.0K$56.0K$58.0K
    Retained Earnings-$138.50M-$199.43M-$277.71M-$367.46M-$413.88M-$391.07M-$459.64M-$451.07M-$467.82M
    Total Equity$115.50M$74.57M$132.04M$88.29M$75.93M$106.89M$46.12M$59.02M$44.20M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$39.63M-$50.02M-$85.87M-$64.35M-$7.73M-$32.99M-$23.44M-$12.62M$19.58M
    Cash from Investing-$83.16M$29.53M$10.47M$7.67M$33.81M$0
    Cash from Financing$69.52M$16.14M$130.88M$84.05M-$29.55M$221.0K$0
    SummaryCapital Expenditure-$2.44M-$314.0K-$157.0K
    Free Cash Flow-$42.06M-$50.33M-$86.03M
    FCF Margin-1060.5%-277.4%-922.1%

    Ratios